Moreover, the expression levels of MSX1 in NK-cell lines were similar when compared to primary NK/T-cell lymphoma patient samples (Figure 1C), supporting our observation of aberrantly reduced MSX1 activity in NK-cell malignancies. The gene discussed is MSX1; the disease is T-cell non-Hodgkin lymphoma.